{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:15:35Z","timestamp":1792318535734,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iLIVER"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.iliver.2024.100081","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T03:20:43Z","timestamp":1707362443000},"page":"100081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors for esophagogastric variceal-related poor outcomes in primary biliary cholangitis: A prospective cohort study"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1874-0413","authenticated-orcid":false,"given":"Lin","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Mei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Long","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Sheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Sheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Feng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2570-9206","authenticated-orcid":false,"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iliver.2024.100081_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.iliver.2024.100081_bib2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/apt.16602","article-title":"Review article: therapeutic aspects of bile acid signalling in the gut-liver axis","volume":"54","author":"Simbrunner","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.iliver.2024.100081_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","article-title":"APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis","volume":"16","author":"You","year":"2022","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.iliver.2024.100081_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/00365521.2015.1132337","article-title":"Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis","volume":"51","author":"Juliusson","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.iliver.2024.100081_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.iliver.2024.100081_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.iliver.2024.100081_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.iliver.2024.100081_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A\u00a0model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.iliver.2024.100081_bib9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.iliver.2024.100081_bib10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis","volume":"7","author":"Loaeza-del-Castillo","year":"2008","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.iliver.2024.100081_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10620-019-05809-x","article-title":"Race\/ethnicity and insurance-specific disparities in in-hospital mortality among adults with primary biliary cholangitis: analysis of 2007-2014 national inpatient sample","volume":"65","author":"Galoosian","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.iliver.2024.100081_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00535-021-01839-3","article-title":"Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis","volume":"57","author":"Burghart","year":"2022","journal-title":"J\u00a0Gastroenterol"},{"issue":"2","key":"10.1016\/j.iliver.2024.100081_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ajg.2017.440","article-title":"Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: risk factors and time trends in incidence and outcome","volume":"113","author":"Harms","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.iliver.2024.100081_bib14","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.14309\/ajg.0000000000000690","article-title":"Novel anti-hexokinase 1 antibodies are associated with poor prognosis in patients with primary biliary cholangitis","volume":"115","author":"Reig","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.iliver.2024.100081_bib15","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.14309\/ajg.0000000000000765","article-title":"Role of antinuclear antibodies in primary biliary cholangitis","volume":"115","author":"Levy","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.iliver.2024.100081_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.13927","article-title":"The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210","volume":"45","author":"Yang","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.iliver.2024.100081_bib17","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3748\/wjg.v29.i12.1795","article-title":"Role of autoantibodies in the clinical management of primary biliary cholangitis","volume":"29","author":"Rigopoulou","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.iliver.2024.100081_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2013.801461","article-title":"Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease","volume":"46","author":"Gatselis","year":"2013","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.iliver.2024.100081_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.iliver.2022.11.004","article-title":"Position statement of Hepatology Society, Dhaka, Bangladesh, on the management of acute variceal bleeding in a resource-limited setting","volume":"1","author":"Ahmad","year":"2022","journal-title":"iLIVER"},{"issue":"12","key":"10.1016\/j.iliver.2024.100081_bib20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrgastro.2015.187","article-title":"Primary biliary cirrhosis: renaming primary biliary cirrhosis-clarity or confusion?","volume":"12","author":"Trivedi","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.iliver.2024.100081_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cld.2021.08.003","article-title":"Endoscopic treatment of esophageal varices","volume":"26","author":"Zuckerman","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.iliver.2024.100081_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.iliver.2023.08.005","article-title":"The evolution of available pharmacological treatments for variceal bleeding secondary to portal hypertension: a scope review","volume":"2","author":"Coser","year":"2023","journal-title":"iLIVER"},{"issue":"12","key":"10.1016\/j.iliver.2024.100081_bib23","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/MEG.0000000000002033","article-title":"Portal hypertension in primary biliary cholangitis: prevalence, natural history and histological correlates","volume":"33","author":"Warnes","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.iliver.2024.100081_bib24","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/MCG.0b013e3181f18c4e","article-title":"Varices in early histological stage primary biliary cirrhosis","volume":"45","author":"Ali","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.iliver.2024.100081_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/liv.15289","article-title":"Portal pressure is of significant prognostic value in primary biliary cholangitis","volume":"43","author":"Warnes","year":"2023","journal-title":"Liver Int"}],"container-title":["iLIVER"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947824000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947824000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:37:30Z","timestamp":1757425050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772947824000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2772947824000069"],"URL":"https:\/\/doi.org\/10.1016\/j.iliver.2024.100081","relation":{},"ISSN":["2772-9478"],"issn-type":[{"value":"2772-9478","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for esophagogastric variceal-related poor outcomes in primary biliary cholangitis: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"iLIVER","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iliver.2024.100081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}],"article-number":"100081"}}